首页> 外文OA文献 >Taste masking of an active pharmaceutical ingredient for veterinary application
【2h】

Taste masking of an active pharmaceutical ingredient for veterinary application

机译:品尝用于兽医应用的活性药物成分的掩蔽

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this thesis was to mask the bitter taste of praziquantel. The product into which the taste masked formulations were to be incorporated was an oral paste intended for the treatment of cats. Four different approaches to achieve taste masking were tested. First of all, microspheres with the active ingredient being embedded into a polymer matrix consisting of Eudragit E were produced. Moreover, taste masking as a result of complexation with β-cyclodextrin was tested as the formation of a true inclusion complex of praziquantel in β-cyclodextrin could be demonstrated. Another technique included incorporation into lipid microparticles. Finally, praziquantel being a racemic drug the isolated enantiomers were tested separately for their acceptance. The taste masked formulations were then incorporated into different pastes (bases: water, Miglyol or PEG) according to their properties and the acceptance by cats was tested. A poor result was scored for the Eudragit E microspheres in PEG which was mainly caused by the solubility of the active ingredient in this base. The drug-β-cyclodextrin complex and the lipid particles were both tested in Miglyol and water. In an oily paste rather low acceptance values were scored whereas in an aqueous paste satisfactory levels were reached. These could be increased slightly upon addition of a flavor. This result could be equaled with an in situ formed complex between praziquantel and β-cyclodextrin in an aqueous paste which was desired due to production and registration purposes. The separated praziquantel enantiomers were also tested in water and significantly different values were reached for them with (−)-praziquantel being preferred to its (+)-enantiomer. The acceptance level for (−)praziquantel, however, was not significantly lower than that of the paste containing β-cyclodextrin and a flavor. Hence, an improvement of the results for (−)-praziquantel might be possible if taste masking agents were added. So in conclusion, taste masking of praziquantel was achieved in form of an aqueous paste containing β-cyclodextrin and a flavor as taste masking agents: the resulting paste is willingly taken by cats and also rated easily applicable by pet owners.ud
机译:本文的目的是掩盖吡喹酮的苦味。将要掺入掩味制剂的产品是用于猫治疗的口服糊剂。测试了四种实现掩味的方法。首先,制备了将活性成分包埋在由Eudragit E组成的聚合物基质中的微球。此外,测试了与β-环糊精络合的掩味作用,因为可以证明吡喹酮在β-环糊精中形成真正的包合物。另一种技术包括掺入脂质微粒中。最后,吡喹酮是一种外消旋药物,分离的对映异构体分别进行了接受测试。然后根据掩味剂的性质将其掩盖在不同的糊剂(碱:水,Miglyol或PEG)中,并测试猫的接受度。 PEG中的Eudragit E微球评分不佳,主要是由于活性成分在该碱中的溶解度所致。药物-β-环糊精复合物和脂质颗粒均在Miglyol和水中测试。在油性糊剂中得分较低,而在水性糊剂中达到令人满意的水平。添加调味剂后,这些含量可能会略有增加。该结果可以等同于吡喹酮与β-环糊精在水性糊剂中原位形成的络合物,这是由于生产和配准目的所希望的。在水中也测试了分离的吡喹酮对映体,并且达到了显着不同的值,其中(-)-吡喹酮优于其(+)-对映体。然而,(-)吡喹酮的接受水平并不明显低于包含β-环糊精和香料的糊剂的接受水平。因此,如果添加了掩味剂,可能会改善(-)-吡喹酮的结果。因此,总的来说,吡喹酮的味觉掩盖是通过以β-环糊精和芳香剂作为味觉掩盖剂的水性糊剂形式实现的:所得的糊剂被猫愿意服用,也很容易被宠物主人评价。

著录项

  • 作者

    Oppel Katrin;

  • 作者单位
  • 年度 2008
  • 总页数
  • 原文格式 PDF
  • 正文语种 {"code":"en","name":"English","id":9}
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号